An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy.
暂无分享,去创建一个
Martin G Pomper | Peter B Barker | Eva L Feldman | Ruth C Carlos | Myria Petrou | Robert C Welsh | Richard A E Edden | M. Pomper | R. Edden | P. Barker | R. Welsh | M. Petrou | E. Feldman | R. Carlos | M. Mohamed | B. Foerster | B. Callaghan | Bradley R Foerster | Brian C Callaghan | Mona A Mohamed
[1] E. Kunesch,et al. Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis , 2001, Annals of neurology.
[2] Laura E. Danielian,et al. White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. , 2011, Brain : a journal of neurology.
[3] C. Zona,et al. Modulation of AMPA receptors in spinal motor neurons by the neuroprotective agent riluzole , 2004, Journal of neuroscience research.
[4] M A Horsfield,et al. Diffusion tensor MRI assesses corticospinal tract damage in ALS , 1999, Neurology.
[5] W. Fischer,et al. Riluzole suppresses motor cortex facilitation in correlation to its plasma level , 2000, Experimental Brain Research.
[6] Measuring pseudobulbar affect in ALS , 2004, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[7] C. Hanstock,et al. Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy. , 2006, Archives of neurology.
[8] Matthew C Kiernan,et al. Biomarkers in amyotrophic lateral sclerosis , 2009, The Lancet Neurology.
[9] J. Rothstein,et al. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis , 2009, Annals of neurology.
[10] S. Petri,et al. Hyperexcitability and amyotrophic lateral sclerosis , 2012, Neurology.
[11] H. Mitsumoto,et al. Amyotrophic lateral sclerosis: Objective upper motor neuron markers , 2002, Current neurology and neuroscience reports.
[12] A. Nistri,et al. Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro , 2008, The European journal of neuroscience.
[13] P. Matthews,et al. Polarity-Sensitive Modulation of Cortical Neurotransmitters by Transcranial Stimulation , 2009, The Journal of Neuroscience.
[14] Michel Modo,et al. Advances in the application of MRI to amyotrophic lateral sclerosis. , 2010, Expert opinion on medical diagnostics.
[15] Douglas L. Arnold,et al. Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging , 2006, Journal of Neurology.
[16] Alessandra Cifra,et al. Riluzole: what it does to spinal and brainstem neurons and how it does it. , 2013, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[17] Richard W. Bohannon,et al. Interrater reliability of a modified Ashworth scale of muscle spasticity. , 1987, Physical therapy.
[18] R. Miller,et al. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[19] P. Leigh,et al. Dose-ranging study of riluzole in amyotrophic lateral sclerosis , 1996, The Lancet.
[20] M. Filippi,et al. The Present and the Future of Neuroimaging in Amyotrophic Lateral Sclerosis , 2010, American Journal of Neuroradiology.
[21] F Träber,et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. , 1998, Archives of neurology.
[22] N Filippini,et al. Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis , 2010, Neurology.
[23] Peter B Barker,et al. Spatial effects in the detection of γ‐aminobutyric acid: Improved sensitivity at high fields using inner volume saturation , 2007, Magnetic resonance in medicine.
[24] A. Eisen,et al. Duration of amyotrophic lateral sclerosis is age dependent , 1993, Muscle & nerve.
[25] A Al-Chalabi,et al. Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[26] A. Doble. The pharmacology and mechanism of action of riluzole , 1996, Neurology.
[27] M. Turner,et al. Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis? , 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[28] M. Garwood,et al. Simultaneous in vivo spectral editing and water suppression , 1998, NMR in biomedicine.
[29] M. Swash,et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[30] T L Chenevert,et al. Decreased motor cortex γ-aminobutyric acid in amyotrophic lateral sclerosis , 2012, Neurology.
[31] Steven Knight,et al. Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis. , 2011, Brain : a journal of neurology.
[32] D. Arnold,et al. Recovery of N‐acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy , 1998, Neuroreport.
[33] Jing Han,et al. Study of the features of proton MR spectroscopy (1H‐MRS) on amyotrophic lateral sclerosis , 2010, Journal of magnetic resonance imaging : JMRI.
[34] M. Kiernan,et al. Riluzole, neuroprotection and amyotrophic lateral sclerosis. , 2010, Current medicinal chemistry.
[35] P M Pattany,et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. , 2000, AJNR. American journal of neuroradiology.
[36] C. Zorumski,et al. Neuroprotective agent riluzole potentiates postsynaptic GABAA receptor function , 2002, Neuropharmacology.
[37] M. Lauritzen,et al. Reduced GABAergic inhibition explains cortical hyperexcitability in the wobbler mouse model of ALS. , 2011, Cerebral cortex.
[38] P. Pattany,et al. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis , 1999, Journal of the Neurological Sciences.
[39] S. Provencher. Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.
[40] K. Uğurbil,et al. In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: Metabolite quantification at 4T vs. 7T , 2009, Magnetic resonance in medicine.
[41] S. Petri,et al. Distribution of GABAA Receptor mRNA in the Motor Cortex of ALS Patients , 2003, Journal of neuropathology and experimental neurology.
[42] A. Ludolph,et al. Protective Effects of Riluzole on Dopamine Neurons , 2000, Journal of neurochemistry.
[43] P. Sundgren,et al. Magnetic resonance spectroscopy. , 2005, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[44] F. Turkheimer,et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study , 2004, Neurobiology of Disease.
[45] M. Swash. Why are upper motor neuron signs difficult to elicit in amyotrophic lateral sclerosis? , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[46] T. Ng,et al. 1H-MRS evidence of neurodegeneration and excess glutamate glutamine in ALS medulla , 1999, Neurology.
[47] M. Gobbi,et al. Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. , 2008, European journal of pharmacology.
[48] Robert G. Miller,et al. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). , 2012, The Cochrane database of systematic reviews.
[49] J. Mantz,et al. Riluzole, a novel antiglutamate, blocks GABA uptake by striatal synaptosomes. , 1994, European journal of pharmacology.
[50] R. Edden,et al. In vivo magnetic resonance spectroscopy of GABA: a methodological review. , 2012, Progress in nuclear magnetic resonance spectroscopy.